pharmaceutical investing Novartis reports erenumab met all primary and secondary endpoints in unique Phase IIIb study in episodic migraine patients
LaFleur Minerals Commences Diamond Drilling at the Swanson Gold Deposit and Completes Independent Valuation of the Beacon Gold Mill
